BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8508386)

  • 1. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
    Doerr RJ; Herrera L; Abdel-Nabi H
    Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.
    Doerr RJ; Abdel-Nabi H; Merchant B
    Arch Surg; 1990 Feb; 125(2):226-9. PubMed ID: 2302062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
    Abdel-Nabi HH; Doerr RJ
    Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
    Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
    Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results.
    Abdel-Nabi H; Doerr RJ; Chan HW; Balu D; Schmelter RF; Maguire RT
    Radiology; 1990 Apr; 175(1):163-71. PubMed ID: 2315476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.
    Chetanneau A; Barbet J; Peltier P; Le Doussal JM; Gruaz-Guyon A; Bernard AM; Resche I; Rouvier E; Bourguet P; Delaage M
    Nucl Med Commun; 1994 Dec; 15(12):972-80. PubMed ID: 7715897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
    Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
    Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
    Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
    Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
    Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
    Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and role of repeated administrations of Indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE 025 in the postoperative follow-up of colorectal carcinoma patients.
    Abdel-Nabi HH; Doerr RJ; Chan HW; Farrell E; Evans NH; Spaulding MB; Schweighardt S; Merchant EB
    J Nucl Med; 1992 Jan; 33(1):14-22. PubMed ID: 1730980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
    Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
    Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of radioimmunoguided surgery for pelvic recurrence.
    Haddad R; Avital S; Troitsa A; Chen J; Baratz M; Brazovsky E; Gitstein G; Kashtan H; Skornick Y; Schneebaum S
    Eur J Surg Oncol; 2001 Apr; 27(3):298-301. PubMed ID: 11373109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.